IRIS
QUARTUCCIO, Luca
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 13.182
AS - Asia 6.755
EU - Europa 4.007
SA - Sud America 1.417
AF - Africa 151
OC - Oceania 9
Continente sconosciuto - Info sul continente non disponibili 8
AN - Antartide 1
Totale 25.530
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 12.995
SG - Singapore 3.226
CN - Cina 1.424
BR - Brasile 1.171
UA - Ucraina 1.056
HK - Hong Kong 773
DE - Germania 633
IT - Italia 592
VN - Vietnam 557
RU - Federazione Russa 358
FI - Finlandia 330
IE - Irlanda 240
SE - Svezia 220
GB - Regno Unito 217
TR - Turchia 163
IN - India 123
KR - Corea 111
CA - Canada 106
AR - Argentina 95
FR - Francia 71
BD - Bangladesh 69
AT - Austria 65
ZA - Sudafrica 52
EC - Ecuador 50
ID - Indonesia 48
MX - Messico 44
IQ - Iraq 41
PL - Polonia 41
JP - Giappone 40
NL - Olanda 37
CO - Colombia 31
ES - Italia 30
CZ - Repubblica Ceca 27
IR - Iran 27
EG - Egitto 21
MA - Marocco 20
TG - Togo 20
BE - Belgio 19
PK - Pakistan 19
PY - Paraguay 19
CL - Cile 18
LT - Lituania 16
UZ - Uzbekistan 16
AE - Emirati Arabi Uniti 15
TN - Tunisia 11
PE - Perù 10
SA - Arabia Saudita 10
JO - Giordania 9
KE - Kenya 9
KZ - Kazakistan 9
PT - Portogallo 9
VE - Venezuela 9
IL - Israele 8
TT - Trinidad e Tobago 8
AZ - Azerbaigian 7
BO - Bolivia 7
GR - Grecia 7
JM - Giamaica 7
LB - Libano 7
OM - Oman 7
UY - Uruguay 7
CR - Costa Rica 6
DO - Repubblica Dominicana 6
EE - Estonia 6
EU - Europa 6
MY - Malesia 6
NP - Nepal 6
LK - Sri Lanka 5
NZ - Nuova Zelanda 5
RO - Romania 5
AL - Albania 4
BY - Bielorussia 4
KG - Kirghizistan 4
TW - Taiwan 4
AU - Australia 3
BN - Brunei Darussalam 3
CH - Svizzera 3
DZ - Algeria 3
GA - Gabon 3
HR - Croazia 3
PH - Filippine 3
BB - Barbados 2
BH - Bahrain 2
BW - Botswana 2
CI - Costa d'Avorio 2
CY - Cipro 2
DK - Danimarca 2
DM - Dominica 2
ET - Etiopia 2
KW - Kuwait 2
LV - Lettonia 2
NO - Norvegia 2
PA - Panama 2
XK - ???statistics.table.value.countryCode.XK??? 2
AM - Armenia 1
AO - Angola 1
AQ - Antartide 1
BA - Bosnia-Erzegovina 1
BG - Bulgaria 1
CG - Congo 1
Totale 25.507
Salva come PNG Salva come JPEG
Città #
Woodbridge 1.633
Singapore 1.247
Ann Arbor 1.122
Fairfield 1.061
Houston 967
Ashburn 963
Beijing 802
Chandler 767
Hong Kong 761
Jacksonville 680
Wilmington 519
Seattle 439
Dearborn 414
Boardman 352
Cambridge 335
Dublin 236
Princeton 229
Los Angeles 206
Udine 178
Ho Chi Minh City 177
Dallas 149
Izmir 138
Hefei 129
São Paulo 116
Buffalo 111
Seoul 105
Redondo Beach 97
Hanoi 88
Des Moines 83
Dong Ket 80
Munich 79
San Diego 79
Nuremberg 67
New York 62
Ogden 60
Norwalk 50
Ottawa 43
Redmond 41
Nanjing 38
Warsaw 38
London 37
Milan 35
Rio de Janeiro 35
Santa Clara 35
Johannesburg 30
Brooklyn 28
Mumbai 28
Frankfurt am Main 27
Trieste 27
Belluno 26
Belo Horizonte 26
San Mateo 26
Stockholm 26
Tokyo 26
Denver 25
Lappeenranta 25
Phoenix 25
Atlanta 24
Chennai 24
Düsseldorf 24
Helsinki 23
Montreal 23
Guangzhou 22
Toronto 22
Brasília 21
Brno 21
Curitiba 21
Orem 21
Vienna 21
Lomé 20
Da Nang 19
Haiphong 19
Turku 19
Amsterdam 18
Brussels 18
Chicago 18
Guayaquil 18
The Dalles 18
Quito 17
Biên Hòa 16
Council Bluffs 16
Kunming 16
Porto Alegre 16
Rome 16
Tashkent 16
Auburn Hills 15
Boston 15
Falls Church 15
Lauterbourg 15
Mexico City 15
Salvador 15
Goiânia 14
Poplar 14
Ribeirão Preto 14
Augusta 13
Baghdad 13
Campinas 12
Shanghai 12
Simi Valley 12
Buenos Aires 11
Totale 15.980
Salva come PNG Salva come JPEG
Nome #
Efficacy and safety of belimumab in primary Sjogren's syndrome: results of the BELISS open-label phase II study. 186
Differentiation between early rheumatoid and early psoriatic arthritis by the ultrasonographic study of the synovio-entheseal complex of the small joints of the hands 177
Biomarkers of lymphoma in Sjögren's syndrome and evaluation of the lymphoma risk in prelymphomatous conditions: results of a multicenter study. 172
Pain management in cryoglobulinaemic syndrome 171
Validation of the classification criteria for cryoglobulinaemic vasculitis. 170
Gitelman syndrome disclosed by calcium pyrophosphate deposition disease: Early diagnosis by ultrasonographic study 170
AB0695 Anti-prothrombin/phosphatidyl-serine complex autoantibodies in antiphospholipid syndrome: Preliminary data using a new ELISA method 167
A randomized controlled trial of rituximab for treatment of severe cryoglobulinemic vasculitis. 164
Pachydermodactyly: The role of ultrasonography and dermoscopy for diagnosis 161
Recommendations for the management of mixed cryoglobulinemia syndrome in hepatitis C virus-infected patients 159
A randomized, controlled, multicenter phase iii study of the efficacy and safety of rituximab (rtx) monotherapy versus the best available treatment (bat) in patients with mixed cryoglobulinemia syndrome (MC) Ann Rheum Dis 2010;69(Suppl3):93 159
The CC homozygosis of the -174G>C IL-6 polymorphism predicts a lower efficacy of rituximab therapy in rheumatoid arthritis 159
Retreatment regimen of rituximab monotherapy given at the relapse of severe HCV-related cryoglobulinemic vasculitis: Long-term follow up data of a randomized controlled multicentre study 159
Accuracy of Computer-Guided Flapless Implant Surgery in Fully Edentulous Arches and in Edentulous Arches With Fresh Extraction Sockets 158
Serum Jo-1 Autoantibody and Isolated Arthritis in the Antisynthetase Syndrome: Review of the Literature and Report of the Experience of AENEAS Collaborative Group 154
Acetaminophen-induced liver injury in a woman with febrile flare of systemic lupus erythematosus 153
Prevalence of mixed cryoglobulinaemia syndrome and circulating cryoglobulins in a population-based survey: the Origgio study. 152
Use of teriparatide in osteoporosis due to active rheumatic diseases 151
Italian consensus Guidelines for the management of hepatitis B virus infections in patients with rheumatoid arthritis 151
Treatment with belimumab restores B cell subsets and their expression of B cell activating factor receptor in patients with primary Sjogren's syndrome 150
A B-cell activating factor receptor (BAFF-R) His159Tyr mutation in Sjögren's Syndrome related lymphoproliferation 149
Cryoglobulinaemia related to Sjogren's syndrome or HCV infection: differences based on the pattern of bone marrow involvement, lymphoma evolution and laboratory tests after parotidectomy. 148
Clinical and biological differences between cryoglobulinaemic and hypergammaglobulinaemic purpura in primary Sjögren's syndrome: results of a large multicentre study. 148
Increased genomic instability following treatment with direct acting anti-hepatitis C virus drugs 146
Therapeutic options after treatment failure in rheumatoid arthritis or spondyloarthritides. 145
HCV-related liver and lymphoproliferative diseases: Association with polymorphisms of IL28B and TLR2 145
Efficacy of intravenous cyclosporine in a case of cytophagic histiocytic panniculitis complicated by haemophagocytic syndrome after visceral leishmania infection 144
BLyS upregulation in Sjogren's syndrome associated with lymphoproliferative disorders, higher ESSDAI score and B-cell clonal expansion in the salivary glands 142
Optimizing the dose of mycophenolate mofetil for the maintenance treatment of lupus nephritis by therapeutic drug monitoring. 142
Atypical lymphoproliferation progressing into B-cell lymphoma in rheumatoid arthritis treated with different biological agents: clinical course and molecular characterization. 142
Retrospective analysis of the usefulness of a protocol with high-dose methotrexate in polymyalgia rheumatica: Results of a single-center cohort of 100 patients 142
Strontium ranelate and femural fracture healing during rheumatoid arthritis and osteoporosis 141
Patient-reported impact of spondyloarthritis on work disability and working life: The ATLANTIS survey 141
The 158VV Fcgamma receptor 3A genotype is associated with response to rituximab in rheumatoid arthritis: results of an Italian multicentre study. 141
A randomized, controlled, multicenter phase III study of the efficacy and safety of rituximab (rtx) monotherapy versus the best available treatment (bat) in patients with mixed cryoglobulinemia syndrome (MC) 140
Development of the ClinESSDAI: A clinical score without biological domain. A tool for biological studies 139
Apheresis treatment of cryoglobulinemic vasculitis: A multicentre cohort study of 159 patients 139
Cost-effectiveness analysis of two Rituximab retreatment regimens for longstanding rheumatoid arthritis. 139
Clinical follow-up predictors of disease pattern change in anti-Jo1 positive anti-synthetase syndrome: Results from a multicenter, international and retrospective study 136
Treatment of rheumatoid arthritis with rituximab: an update and possible indications. 135
Anti-SSA/SSB-negative Sjögren's syndrome shows a lower prevalence of lymphoproliferative manifestations, and a lower risk of lymphoma evolution 135
Italian consensus recommendations for the management of hepatitis C infection in patients with rheumatoid arthritis 135
Rituximab monotherapy, rather than rituximab plus antiviral drugs, for initial treatment of severe hepatitis C virus-associated mixed cryoglobulinemia syndrome: comment on the article by Terrier et al 134
Rheumatoid factor positivity rather than anti-CCP positivity, a lower disability and a lower number of anti-TNF agents failed are associated with response to rituximab in rheumatoid arthritis 134
Introducing treat-to-target strategies of autoimmune extrahepatic manifestations of chronic hepatitis C virus infection 133
Role e of oral cyclophosphamide in the treatment of giant cell arteritis 132
Sequential therapy with belimumab followed by rituximab in Sjögren's syndrome associated with B-cell lymphoproliferation and overexpression of BAFF: evidence for long-term efficacy. 132
L. Quartuccio, M. Fabris, M. Maset, E. Pontarini, A. Zabotti, S. De Vita Bone marrow b-cell expansion in mixed cryoglobulinemia: association with nephritis and response to rituximab 131
B lymphocyte stimulator (BLyS) and monocytes: possible role in autoimmune diseases with a particular reference to rheumatoid arthritis 131
Dermoscopy of nail fold and elbow in the differential diagnosis of early psoriatic arthritis sine psoriasis and early rheumatoid arthritis 129
Alveolar haemorrhage in ANCA-associated vasculitis: Long-term outcome and mortality predictors 129
Classification of cryoglobulinemic vasculitis 128
Mycophenolic Acid AUC estimation in patients with lupus nephritis using an algorithm validated in an heart transplanted population 128
Cardiovascular disease risk burden in primary Sjögren's syndrome: results of a population-based multicentre cohort study. 125
A TGF-β associated genetic score to define prognosis and platinum sensitivity in advanced epithelial ovarian cancer 125
A retrospective, multicenter study evaluating the prognostic value of minor salivary gland histology in a large cohort of patients with primary Sjögren's syndrome. 123
Comment on: Rheumatoid factor positivity rather than anti-CCP positivity, a lower disability and a lower number of anti-TNF agents failed are associated with response to rituximab in rheumatoid arthritis: reply 123
Pregnancy and fetal outcome in patients with an established diagnosis of primary sjögren's syndrome 122
Variations in lumbar and femural bmd after rituximab therapy in active rheumatoid arthritis 122
Gastrointestinal Involvement in Systemic Vasculitis 122
Myositis in primary sjögren's syndrome: data from a multicenter cohort 121
Efficacy and tolerability of repeated cycles of a once-weekly regimen of bortezomib in lupus. 121
Long-term Efficacy of Interferon-Free Antiviral Treatment Regimens in Patients With Hepatitis C Virus-Associated Cryoglobulinemia Vasculitis 121
Development of type II mixed cryoglobulinaemic syndrome after effective and persistent hepatitis C virus eradication. 120
Late relapses of hepatitis C virus-cured mixed cryoglobulinaemia associated with infection or cancer 120
HCV-unrelated cryoglobulinaemic vasculitis: the results of a prospective observational study by the Italian Group for the Study of Cryoglobulinaemias (GISC) 119
Ultrasonographic detection of subclinical enthesitis and synovitis: a possible stratification of psoriatic patients without clinical musculoskeletal involvement 119
Pleuritis is a red flag for Adult-onset Still's disease which may require biologic therapies. 118
A randomized, controlled, multicenter phase III study of the efficacy and safety of Rituximab (RTX) monotherapy versus thebest available treatment in patients with mixedcryoglobulinemia syndrome, on behalf of the rituximab studygroup in cryoglobulinemic sindrome. 118
Type I interferon signature may influence the effect of belimumab on immunoglobulin levels, including rheumatoid factor in Sjögren's syndrome 118
A clinical-genetic score to identify surgically resected colorectal cancer patients benefiting from an adjuvant fluoropyrimidine-based therapy 118
Rituximab as possible first-line therapy for glomerulonephritis in HCV-related mixed cryoglobulinaemia 115
Fetal Outcome in Patients with an Established Diagnosis of Primary Sjögren’s Syndrome 114
Ciclosporina e tacrolimus nella miosite da corpi inclusi: efficacia clinica, sicurezza e risparmio nell'uso dei corticosteroidi 114
Clinical characterization and treatment outcome in a monocentric cohort of 45 patients with adult onset still's disease 114
Preliminary classification criteria for the cryoglobulinaemic vasculitis 114
Safety of Rituximab in different rheumatic autoimmune diseases. A single centre experience in 85 cases. 2008 113
Correction: Polymorphisms at phase I-metabolizing enzyme and hormone receptor loci influence the response to anti-TNF therapy in rheumatoid arthritis patients 113
Articular and peripheral nervous system involvement are linked to the long-term outcome in primary Sjögren's syndrome: The relevance of single organ manifestations rather than a composite score as predictors 113
B-Lymphocyte Stimulator (BLyS) in mixed cryoglobulinemia sindrome: pathobiological and clinical implication 112
The role of the il-6 promoter p in predicting rituximab efficacy in rheumatoid artolymorphism 112
Efficacy of cyclosporin-A in the long-term management of thrombocytopenia associated with systemic lupus erythematosus 111
Efficacy of belimumab and targeting of rheumatoid factor-positive B-cell expansion in Sjögren's syndrome: follow-up after the end of the phase II open-label BELISS study 111
The-308 TNFα and the -174 IL-6 promoter polymorphisms associate with effective anti-TNFα treatment in seronegative spondyloarthritis 111
Delayed Positivization of Cerebral Angiography in Reversible Cerebral Vasoconstriction Syndrome (RCVS) Presenting with Recurrent Subarachnoid Haemorrhage. 111
Rheumatoid factor positivity, a lower disability and a lower number of anti-tnf agents failed are associated with response to rituximab in rheumatoid arthritis 110
Gastrointestinal involvement in systemic vasculitis 110
Long-term efficacy and improvement of health-related quality of life in patients with Takayasu's arteritis treated with infliximab. 109
efficacy of methotrexate in polymyalgia rheumatica 109
Disappearance of bone marrow B cell clonal expansion in patients with type II hepatitis C virus-related cryoglobulinemic glomerulonephritis after clinical efficient rituximab therapy. 109
Polymorphisms at phase I-metabolizing enzyme and hormone receptor loci influence the response to anti-TNF therapy in rheumatoid arthritis patients 109
Association between bone marrow B cell clonal expansion and glomerulonephritis in type II mixed cryoglobulinaemia 107
High prevalence of Chlamydophila psittaci subclinical infection in Italian patients with Sjögren's syndrome and parotid gland marginal zone B-cell lymphoma of MALT-type. 106
Association be tween B cell clonal expansion and glomerulonephritis in type cryoglobulinnaemia. 2007; 66 (Suppl. II): 121 106
Association be tween B cell clonal expansion and glomerulonephritis in type cryoglobulinnaemia 106
Efficacy of Belimumab On Non-Malignant Parotid Swelling and Systemic Manifestations of Sjo¨gren’s Syndrome: Results of the Beliss Study. 105
prevalence of chlamydophila psittaci subclinical infection in italian patients with rheumatoid arthritis: etiopathological and therapeutic implications 104
Study on the possible role of the -174G>C IL-6 promoter polymorphism in predicting response to rituximab in rheumatoid arthritis 104
Early Psoriatic Arthritis Versus Early Seronegative Rheumatoid Arthritis: Role of Dermoscopy Combined with Ultrasonography for Differential Diagnosis 104
Clinical Spectrum Time Course in Anti Jo-1 Positive Antisynthetase Syndrome: Results From an International Retrospective Multicenter Study 103
Totale 13.152
Salva come PNG Salva come JPEG
Categoria #
all - tutte 110.428
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 110.428
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20211.712 0 0 0 0 0 275 67 258 527 84 325 176
2021/20221.678 62 173 89 138 44 48 91 109 25 235 369 295
2022/20232.035 248 95 38 221 208 544 35 147 296 38 77 88
2023/2024763 109 62 29 19 144 89 30 64 99 60 21 37
2024/20255.380 121 403 231 158 236 233 337 358 709 492 771 1.331
2025/20265.888 789 1.026 943 1.044 1.543 543 0 0 0 0 0 0
Totale 26.458